Oracle co-founder and Chief Technology Officer Larry Ellison has officially leapfrogged Meta Platforms CEO Mark Zuckerberg to take the position of the world’s second-richest person, with an estimated net worth of $251 billion according to the Bloomberg Billionaires Index. This milestone comes on the heels of Oracle’s rising market capitalization and the software giant’s robust advances in the fast-evolving field of artificial intelligence (AI), particularly in healthcare applications.

Ellison’s net worth has soared by $59 billion in 2024 alone, placing him directly behind Tesla and SpaceX CEO Elon Musk and ahead of Meta’s Zuckerberg, Amazon founder Jeff Bezos, and Microsoft’s Steve Ballmer. The majority of Ellison’s wealth—more than 80%—is tied to Oracle shares and stock options, making him one of the tech sector’s most prominent and wealthiest founders.

Oracle’s AI Push and Project Stargate

Ellison’s recent ascent is not only a testament to his business acumen but also to Oracle’s strategic shift toward enterprise cloud and AI infrastructure. In June, Oracle shares jumped nearly 6% on the news that U.S. authorities would permit American chipmakers such as Nvidia and Advanced Micro Devices (AMD) to resume exporting certain advanced semiconductors to China, boosting confidence across the U.S. tech sector.

But the most headline-grabbing moment came with the unveiling of “Project Stargate,” a $500 billion AI joint venture endorsed by former President Donald Trump. The initiative aims to revolutionize the battle against cancer by leveraging Oracle’s cloud and AI prowess for early cancer detection and advanced treatment. During the announcement, Ellison outlined how Oracle’s AI-driven healthcare solutions would empower medical professionals with tools for earlier and more accurate screening, expedited diagnoses, and more personalized cancer therapies.

“We are on the cusp of a breakthrough in the use of AI to detect cancers early, which will save millions of lives globally,” Ellison stated at the event, stressing Oracle’s vision to integrate health data, cloud infrastructure, and machine learning models to power healthcare transformation.

Oracle’s Role in the AI Race

Oracle, long known for its dominance in relational databases and enterprise software, has rapidly reinvented itself over the past decade. The company has invested tens of billions into expanding its Oracle Cloud Infrastructure (OCI) and AI services, partnering with leading health providers, government agencies, and major enterprises worldwide.

With competition raging between American tech giants—Microsoft, Google, Meta, and Amazon—over generative AI and cloud AI infrastructure, Oracle has carved out a strong niche by focusing on AI applications in healthcare, financial services, and government. Its AI-driven analytics and data security tools are now staples in hospital systems, insurance, and public health programs globally.

• Oracle’s recent contracts include cloud-based digital health records for the U.K.’s NHS
• U.S. federal agencies deploy Oracle health analytics for pandemic management
• The company’s AI initiatives have drawn partnerships with leading pharmaceutical and biotech firms for drug discovery

Notably, the $500 billion Project Stargate represents the largest tech-healthcare collaboration to date and highlights the scale of investment pouring into AI-powered medicine. Experts say that by integrating diverse diagnostic datasets, clinical trial data, and genetic profiles with powerful AI models, Oracle aims to cut cancer mortality rates while streamlining healthcare costs.

According to IDC, global healthcare AI spending is set to exceed $45 billion in 2024 and is projected to cross $120 billion by 2030, fueled by these large-scale public and private partnerships.

Wealth Surge Driven by Stock Market Gains

Oracle’s stellar performance on Wall Street this year has substantially boosted Ellison’s portfolio. On June 25th, Oracle stock (NYSE: ORCL) hit an all-time high above $241, having surged more than 50% in the past twelve months. Last month alone, Ellison’s net worth jumped by $26 billion as the company’s share price soared.

The technology sector broadly has seen historic gains in 2024, with big tech stocks driving the S&P 500 index up over 14% year-to-date. Oracle’s global cloud push and its healthcare division are central to investor optimism. As AI transforms nearly every field—from finance to logistics to personal health—shareholders are betting that Oracle’s strategic pivot will continue to pay dividends.

The Global Billionaire Rankings

Despite his immense fortune, Ellison’s age and continued hands-on role at Oracle—serving as CTO and chair—underscore his ongoing influence over global technology, healthcare, and business innovation. Bloomberg ranks him as the richest person over 80, highlighting a rare blend of visionary leadership and longevity in the high-pressure world of tech entrepreneurship.

The Road Ahead: Ellison and AI’s Impact on Healthcare

As Oracle’s AI ventures expand—especially in cancer screening, genomics, and drug discovery—the company and Ellison remain at the center of the intersection between cutting-edge technology and human health. Project Stargate, if successful, could redefine global cancer detection standards and reinforce Oracle’s position as a cornerstone of AI-driven transformation.

For investors, clinicians, and technologists alike, Ellison’s leadership is a powerful signal of how AI, cloud computing, and big data are converging to solve some of society’s most intractable challenges. As the world watches, Oracle and its iconic founder are poised to set the agenda for the next era of healthcare and technology.

For further updates on the technology and AI revolution in healthcare, stay tuned to this portal for the latest analysis and market trends.